Literature DB >> 11862397

Alu polymorphism within the MICB gene and association with HLA-B alleles.

Jerzy K Kulski1, David S Dunn, Jennie Hui, Patricia Martinez, Amornrat V Romphruk, Chanvit Leelayuwat, Guan K Tay, Akira Oka, Hidetoshi Inoko.   

Abstract

We describe the finding of an Alu repeat dimorphism within the first intron of the MICB gene. The frequencies of the two AluyMICB alleles, AluyMICB*0(absence of insertion) and AluyMICB*1(presence of insertion), and their associations with the highly polymorphic HLA-B locus were determined for 51 human cell lines and for 109 and 200 Caucasians and northeastern Thais, respectively. Analysis of the AluyMICB and HLA-B allelic relationships revealed that AluyMICB*1 occurred at relatively low gene frequency (0.118-0.157) [corrected] but was strongly associated with HLA-B17 (HLA-B57,HLA-B58) and HLA-B13. The AluyMICB locus provides a useful dimorphic marker for investigations on the level of linkage disequilibrium between MICB, MICA, and HLA-B loci.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862397     DOI: 10.1007/s00251-001-0409-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  3 in total

1.  The distribution of polymorphic Alu insertions within the MHC class I HLA-B7 and HLA-B57 haplotypes.

Authors:  David S Dunn; Brian D Tait; Jerzy K Kulski
Journal:  Immunogenetics       Date:  2004-12-08       Impact factor: 2.846

2.  Association and differentiation of MHC class I and II polymorphic Alu insertions and HLA-A, -B, -C and -DRB1 alleles in the Chinese Han population.

Authors:  Lei Shi; J K Kulski; Hua Zhang; Zhaomei Dong; Danfeng Cao; Jingxian Zhou; Jiankun Yu; Yufeng Yao; Li Shi
Journal:  Mol Genet Genomics       Date:  2013-11-19       Impact factor: 3.291

3.  Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.

Authors:  Xiaoxin Jiang; Ju-Fang Huang; Zhi Huo; Qiuqui Zhang; Yan Jiang; Xiaoping Wu; Yanwen Li; Guanmin Jiang; Leping Zeng; Xiao-Xin Yan; Ping Yu; Renxian Cao
Journal:  BMC Immunol       Date:  2012-11-26       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.